Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Acacia Appoints Matthew Vella To Succeed Paul Ryan As CEO

Patent licensing business firm Acacia Research Corp. (ACTG: Quote) Friday announced the appointment of its current President Matthew Vella as chief executive officer and a director effective August 1, 2013, to succeed Paul Ryan, who will resign from the posts on July 31, 2013.

The company noted that Vella will continue to serve as president of Acacia. Newport Beach, California-based Acacia develops, licenses, and enforces patented technologies in the U.S.

Vella joined Acacia in November 2006 as the firm's vice president and was appointed senior vice president in October 2007. He became Executive Vice President in October 2011 and President in September 2012.

Prior to joining Acacia, Vella was senior intellectual property counsel for ATI Research Inc., Lead Patent License Counsel for Nortel Networks Inc., and counsel for Nortel Networks Corp.

Ryan announced his intention to retire and Executive Chairman Chip Harris stated that the company started working on the succession plan over 18 months ago.

Separately, Acacia said its unit Brandywine Communications Technologies LLC has entered into a settlement agreement with Grandstream Networks, Inc., which resolves patent litigation that was pending in the U.S District Court for the District of Delaware. ACTG closed Thursday's regular trading at $23.14 on the Nasdaq.

Register
To receive FREE breaking news email alerts for Acacia Research Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.